Hydroxy acids and derivatives
Medchemexpress LLC Ketanserin tartrate | 83846-83-7 | MFCD00084651 | 99.9% | 545.51 g/mol | C26H28FN3O9 | 1 ML
Ketanserin tartrate is the tartrate salt of ketanserin, a selective 5-HT2 receptor antagonist that also inhibits hERG current in a concentration-dependent manner. Supplied for research use, it is available as a 10 mM solution in DMSO (1 mL) and as solid quantities, and is accompanied by datasheet, certificate of analysis, and SDS.
Medchemexpress LLC Gluconate-13C6 sodium | 2687960-00-3 | 224.09 | 13C6H11NaO7 | 25mg
Gluconate sodium-13C6 (D-Gluconic acid sodium salt-13C6) is the 13C-labeled Gluconate sodium (HY-B1092A) Gluconate sodium (D-Gluconic acid sodium salt) is an orally active glucose derivative Gluconate sodium reduces nitric oxide and inflammatory cytokines (IL-1 and IL-6) Gluconate sodium inhibits ERK phosphorylation Gluconate sodium has antioxidant and antiplatelet activation activities Gluconate sodium has antitumor activity against colorectal cancer Gluconate sodium improves osteoarthritis intestinal damage and acute lung injury[1][2][3][4][5][6][7]
Medchemexpress LLC 6-Hydroxyhexanoic ac 500mg
6-Hydroxyhexanoic acid (6-HHA) is a biochemical reagent
Accela Chembio Inc (1r | 2r)-(+)-1 | 2-diaminocyclohexane L-tartrate | 100g | 39961-95-0 | MFCD00191979 | 97+% | Shelf Life: 1800 Days | Moisture Sensitive
(1r | 2r)-(+)-1 | 2-diaminocyclohexane L-tartrate | 100g | 39961-95-0 | MFCD00191979 | 97+% | Shelf Life: 1800 Days | Moisture Sensitive
Medchemexpress LLC Brimonidine tartrate (Synonyms: UK 14304 tartrate; AGN190342 tartrate) Solution10 mM * 1 mL in DMSO
Brimonidine tartrate (UK 14304 tartrate) is a full α2-adrenergic receptor (α2-AR) agonist.
Sigma Aldrich Fine Chemicals Biosciences Calcum Gluconate Monhydra500MG
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Medchemexpress LLC Varenicline tartrate | 375815-87-5 | MFCD08460603 | 99.9% | 361.35 | C17H19N3O6 | 50 MG
Varenicline tartrate is the tartrate salt of varenicline, a nicotinic acetylcholine receptor partial agonist. Supplied as a high-purity research chemical for in vitro and analytical applications, it is intended for laboratory use only and not for human or clinical use.
- High purity (≈99.9%).
- CAS number 375815-87-5.
- Molecular weight 361.35 g/mol.
- Appearance: off-white to yellow solid.
- Available in multiple pack sizes, including small milligram quantities and larger bulk options.
- Recommended storage: sealed, away from moisture; in solvent: -80°C (6 months) or -20°C (1 month).
- Biological activity: partial agonist of α4β2 nicotinic acetylcholine receptors (IC50 ≈ 250 nM).
Apexbio Technology LLC Lasofoxifene (tartrate) 190791-29-8 25mg
Lasofoxifene tartrate (CAS 190791-29-8) is a small-molecule selective estrogen receptor modulator (SERM) targeting estrogen receptor-alpha (ER- ) and acting as a selective inverse agonist at the cannabinoid receptor subtype CB2 It is designed to modulate estrogen receptor signaling in a tissue-dependent manner thereby regulating estrogen-related biological pathways Lasofoxifene tartrate exerts its biological activity through dual estrogen agonist antagonist actions depending on tissue context In preclinical studies using ovariectomized rat models Lasofoxifene tartrate prevents estrogen deficiency-associated bone loss reduces serum cholesterol and body mass without inducing uterine hypertrophy Based on these pharmacological properties Lasofoxifene tartrate holds research potential in the management of osteoporosis breast cancer and cardiovascular health in postmenopausal women